Marcus Kaul
- Virology top 0.2%
- HIV Research and Treatment 53
- Neurology top 0.2%
- Neuroinflammation and Neurodegeneration Mechanisms 30
- Biological Psychiatry top 1%
- Tryptophan and brain disorders 9
- Developmental Neuroscience top 2%
-
- interferon and immune responses 11
- Complement system in diseases 6
-
- HIV-related health complications and treatments 7
-
- Alzheimer's disease research and treatments 6
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Stuart A. LiptonGwenn A. GardenRobert LiddingtonJeffrey W. SmithJiankun CuiZezong GuAlex Y. StronginSteven J. Kridel
- Journals
- Journal of Neuroimmune Pharmacology (6 papers)The Journal of Immunology (5 papers)Journal of NeuroVirology (5 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Marcus Kaul
79 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Virology 2.5k
- Neurology 1.7k
- Biological Psychiatry 363
- Developmental Neuroscience 219
- Cellular and Molecular Neuroscience 870
Countries citing papers authored by Marcus Kaul
This map shows the geographic impact of Marcus Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Kaul more than expected).
Fields of papers citing papers by Marcus Kaul
This network shows the impact of papers produced by Marcus Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Kaul. The network helps show where Marcus Kaul may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcus Kaul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 32 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 42 | |
| 8 | 2020 | 13 | |
| 9 | 2019 | 44 | |
| 10 | 2018 | 20 | |
| 11 | 2017 | 37 | |
| 12 | 2016 | 27 | |
| 13 | 2014 | 44 | |
| 14 | 2014 | 30 | |
| 15 | 2009 | 21 | |
| 16 | 2007 | 14 | |
| 17 | 2007 | 96 | |
| 18 | 2002 | 189 | |
| 19 | 2000 | 160 | |
| 20 | 1990 | 11 |
About Marcus Kaul
Marcus Kaul is a scholar working on Virology, Neurology, Biological Psychiatry, Immunology and Emergency Medicine, having authored 81 papers that have together received 5.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (53 papers), Neuroinflammation and Neurodegeneration Mechanisms (30 papers), interferon and immune responses (11 papers), Tryptophan and brain disorders (9 papers), HIV-related health complications and treatments (7 papers), Complement system in diseases (6 papers), Alzheimer's disease research and treatments (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Virology (2.5k citations), Neurology (1.7k citations), Biological Psychiatry (363 citations), Developmental Neuroscience (219 citations) and Cellular and Molecular Neuroscience (870 citations). Marcus Kaul has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Stuart A. Lipton, Gwenn A. Garden, Robert Liddington, Jeffrey W. Smith, Jiankun Cui, Zezong Gu, Alex Y. Strongin, Steven J. Kridel, Shu‐ichi Okamoto and Jialin Zheng. Their work appears in journals such as Journal of Neuroimmune Pharmacology, The Journal of Immunology, Journal of NeuroVirology, Viruses and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.